SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
+6.01%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$552M
AUM Growth
+$552M
(-1.1%)
Cap. Flow
-$48.2M
Cap. Flow
% of AUM
-8.73%
Top 10 Holdings %
Top 10 Hldgs %
71.78%
Holding
134
New
21
Increased
40
Reduced
21
Closed
23
Top Buys
| 1 |
Plains All American Pipeline
PAA
|
$9.17M |
| 2 |
Simplify Aggregate Bond ETF
AGGH
|
$3.48M |
| 3 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$3.15M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$2.64M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$2.57M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$41.7M |
| 2 |
IBDO
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
|
$20.2M |
| 3 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$19.7M |
| 4 |
Invesco QQQ Trust
QQQ
|
$8.84M |
| 5 |
Simplify Volatility Premium ETF
SVOL
|
$8.6M |
Sector Composition
| 1 | Healthcare | 17.63% |
| 2 | Energy | 4.47% |
| 3 | Technology | 0.54% |
| 4 | Industrials | 0.28% |
| 5 | Consumer Discretionary | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kura Oncology
KURA
$732M
| $846K | 0.11% |
80,000
| – | – |
|
77
X4 Pharmaceuticals
XFOR
$70M
| $776K | 0.1% |
13,333
| – | – |
|
|
EIGR
78
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $774K | 0.1% |
36,655
| – | – |
|
79
Idexx Laboratories
IDXX
$50.7B
| $717K | 0.09% |
1,427
-1,512
| -51% | -$759K |
|
80
Boston Scientific
BSX
$159B
| $639K | 0.08% |
11,812
+2,926
| +33% | +$158K |
|
81
AtriCure
ATRC
$1.73B
| $575K | 0.08% |
11,650
+2,882
| +33% | +$142K |
|
82
NVIDIA
NVDA
$4.15T
| $562K | 0.07% |
13,280
-2,140
| -14% | -$90.5K |
|
83
Sutro Biopharma
STRO
$85.6M
| $558K | 0.07% |
120,000
| – | – |
|
84
Tesla
TSLA
$1.08T
| $487K | 0.06% |
1,861
+196
| +12% | +$51.3K |
|
85
UnitedHealth
UNH
$279B
| $479K | 0.06% |
997
-1,665
| -63% | -$800K |
|
86
Microsoft
MSFT
$3.76T
| $468K | 0.06% |
1,375
-1,305
| -49% | -$444K |
|
87
IQVIA
IQV
$31.4B
| $445K | 0.06% |
1,982
-6,043
| -75% | -$1.36M |
|
88
Merck
MRK
$210B
| $438K | 0.06% |
3,797
+946
| +33% | +$109K |
|
89
Advanced Micro Devices
AMD
$263B
| $410K | 0.05% |
3,598
-41
| -1% | -$4.67K |
|
90
Bio-Techne
TECH
$8.3B
| $378K | 0.05% |
4,628
+1,144
| +33% | +$93.4K |
|
91
Heron Therapeutics
HRTX
$204M
| $327K | 0.04% |
281,590
-25,000
| -8% | -$29K |
|
92
QuidelOrtho
QDEL
$1.87B
| $325K | 0.04% |
3,918
+968
| +33% | +$80.2K |
|
93
Amgen
AMGN
$153B
| $304K | 0.04% |
1,369
+334
| +32% | +$74.2K |
|
94
Revvity
RVTY
$9.68B
| $288K | 0.04% |
2,422
-4,366
| -64% | -$519K |
|
95
Humana
HUM
$37.5B
| $280K | 0.04% |
626
-629
| -50% | -$281K |
|
96
Syndax Pharmaceuticals
SNDX
$1.39B
| $268K | 0.04% |
+12,809
| New | +$268K |
|
97
Zoetis
ZTS
$67.6B
| $248K | 0.03% |
+1,443
| New | +$248K |
|
98
Baxter International
BAX
$12.1B
| $244K | 0.03% |
+5,351
| New | +$244K |
|
99
Kymera Therapeutics
KYMR
$3.1B
| $242K | 0.03% |
10,532
| – | – |
|
100
ATAI Life Sciences
ATAI
$969M
| $241K | 0.03% |
140,000
| – | – |
|